AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Breakthrough in Alzheimer's Treatment
This chapter discusses the recent approval of Lecanumab, an Alzheimer's drug that has shown the ability to slow disease progression by 25%. It explores the implications for families, the challenges of diagnosis and treatment access, and the ongoing research into future treatments. The conversation also highlights personal stories and the balance between serious health discussions and lighter, more personal anecdotes.